Evidence map›Paper›PMID 40505522›Full record

ArticleAmerican journal of surgery2025

Medicaid expansion and thyroid cancer stage at presentation: A comparative study of two US states.

Oluwasegun Akinyemi, Terhas Weldeslase, Mojisola Fasokun, Oluebubechukwu Eze, Eunice Odusanya, Austin Yap, Kelsey Limage, Kakra Hughes, Edward Cornwell, Adedoyin Kalejaiye

Abstract readComparative Study
In one paragraph

Article in American journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oluwasegun AkinyemiThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA; Department of Health Policy & Management, University of Maryland School of Public Health, College Park, MD, USA.
Terhas WeldeslaseDepartment of Internal Medicine, Howard University College of Medicine, Washington DC, USA.
Mojisola FasokunDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, USA.
Oluebubechukwu EzeThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA. Electronic address: oluebubechukuwu.eze@bison.howard.edu.
Eunice OdusanyaThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA.
Austin YapThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA.
Kelsey LimageThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA.
Kakra HughesThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA; Department of Surgery, Howard University College of Medicine, Washington DC, USA.
Edward CornwellThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA; Department of Surgery, Howard University College of Medicine, Washington DC, USA.
Adedoyin KalejaiyeThe Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington DC, USA; Department of Surgery, Howard University College of Medicine, Washington DC, USA.

Funding

Sleep Disorders in Adults with Sickle Cell Disease: Frequency, Associations with Cardiovascular and Pain Indicators, and Responses to TreatmentU54MD007597 · NIMHD · HOWARD UNIVERSITY · PI BYRON D. FORD · 2019 to 2026
$37.7M
NIMHD NIH HHS U54 MD007597
6 · The paper itself

Abstract

backgroundThe Affordable Care Act (ACA) enabled states to expand Medicaid eligibility, extending coverage to millions, particularly in California. While Medicaid expansion has been linked to earlier diagnoses in several cancers, its impact on thyroid cancer-a slow-growing malignancy lacking formal screening-remains unclear.

objectiveTo assess whether Medicaid expansion influenced thyroid cancer stage at presentation.

methodsA retrospective cohort study using SEER data (2009-2020) compared adults aged 18-64 diagnosed with thyroid cancer in California (expansion) and Texas (non-expansion). Difference-in-differences logistic regression evaluated stage changes pre- (2009-2013) and post- (2016-2020) expansion, excluding a 2014-2015 washout period.

resultsAmong 63,073 patients, no significant difference in stage at diagnosis was observed between states. Estimates for localized, regional, and distant disease changes ranged from -1.3 ​% to 1.1 ​% (all 95 ​% CIs included zero).

conclusionMedicaid expansion was not associated with a significant shift in thyroid cancer stage at presentation.

Indexed as

MedicaidThyroid NeoplasmsAdolescentAdultCaliforniaFemaleHumansMaleMiddle AgedNeoplasm StagingPatient Protection and Affordable Care ActRetrospective StudiesSEER ProgramTexasUnited StatesYoung AdultAffordable care act policy impactsCancer diagnosis stagesHealth disparitiesMedicaid expansionThyroid cancer outcomes

Identifiers

PMID40505522
PMCPMC12701714

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.